MetaCap

NRX Pharmaceuticals Statistics

NASDAQ: NRXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.15-0.40 (-15.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NRX Pharmaceuticals by the numbers

NRX Pharmaceuticals has a market capitalization of $95.3 million based on 44.33M shares outstanding. With trailing EPS of $-0.33, NRX Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.0% below its 50-day average and 28.0% below its 200-day average.

Average daily trading volume is 1.07M shares, or about $2.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NRXP valuation vs. peer median

NRXP compared with the median of 8 peer companies
MetricNRXPPeer medianDifference
Market cap$95.31M$95.83M-1%
Avg. volume1.07M639.64K+68%

Peer median across 8 companies: PDSB, NBP, DERM, UNCY, CLLS, CNTN, CATX, NERV.

Valuation

Market cap
$95.31M
Price / sales (latest FY)
77.80
EPS (TTM)
$-0.33

Price and trading

Previous close
2.55
Open
2.53
Day range
2.14 – 2.53
52-week range
1.62 – 5.06
52-week change
+0.94%
Beta
—
Volume
1.47M

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
95.31M
Forward Pe
-6.14
Eps
-0.33
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.06
Week52 Low
1.62
Avg Volume
1.07M
Shares Outstanding
44.33M
Ma50
2.72
Ma200
2.99
Earnings Date
Nov 16, 2026
Pct From52w High
-57.47%
Pct From52w Low
32.72%

Related